Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infections.

about

Drug-drug interactions between moxifloxacin and rifampicin based on pharmacokinetics in vivo in rats.What about confidence intervals? A word of caution when interpreting PTA simulations.

P2860

Q35974112-5735FB85-686A-4AB1-83E3-EB3B7A503EF4 Q38871384-354E1BB1-CE00-4639-B92F-5D9996D26F62

P2860

Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infections.

Item

http://www.wikidata.org/entity/Q41534755

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Population pharmacokinetics an ...... with diabetic foot infections.

@en

type

Item

label

Population pharmacokinetics an ...... with diabetic foot infections.

@en

prefLabel

Population pharmacokinetics an ...... with diabetic foot infections.

@en

P1476

Population pharmacokinetics an ...... with diabetic foot infections.

@en

P2093

Charlotte Kloft

http://www.w3.org/2001/XMLSchema#string

Frieder Kees

http://www.w3.org/2001/XMLSchema#string

Karl Zink

http://www.w3.org/2001/XMLSchema#string

Martin G Kees

http://www.w3.org/2001/XMLSchema#string

Sebastian G Wicha

http://www.w3.org/2001/XMLSchema#string

Thomas Haak

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of creatinine clearance from serum creatinine

Development of the quinolones.

A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections

Clinical pharmacodynamics of quinolones.

Pharmacokinetics of moxifloxacin, a novel 8-methoxy-quinolone, in patients with renal dysfunction

Tissue pharmacokinetics of levofloxacin in human soft tissue infections.

What is the best size descriptor to use for pharmacokinetic studies in the obese?

Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans

Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones.

Microdialysis for in vivo pharmacokinetic/pharmacodynamic characterization of anti-infective drugs.

P304

639-646

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.464

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25600294

http://www.w3.org/2001/XMLSchema#string

Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infections.

about

P2860

P2860

Population pharmacokinetics and target attainment analysis of moxifloxacin in patients with diabetic foot infections.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698